Amytrx Therapeutics
PrivateLast Round
Series A
May 25, 2022
Total Funding Raised
$18M
Company Overview
Amytrx Therapeutics is a biopharmaceutical company that develops anti-inflammatory peptide therapies for the treatment of chronic inflammatory and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amytrx Therapeutics Comparables
Compare Amytrx Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Carocell Bio | 76% | |
| Novacell Technology | 76% | |
| PEP-Therapy | 62% |
Amytrx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 25, 2022 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 10, 2024
Monthly visitors grew 419% MoM, from 270 to 1.4K.
- May 25, 2022
$18M round completed.
Amytrx Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Amytrx Therapeutics's valuation, stock price, and market status.
Is Amytrx Therapeutics a public or private company?
Amytrx Therapeutics is a private company.
What is the current stock price of Amytrx Therapeutics?
Amytrx Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Amytrx Therapeutics worth (valuation)?
Valuation information for Amytrx Therapeutics is not publicly available.
Can I buy Amytrx Therapeutics stock?
Amytrx Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Amytrx Therapeutics's last funding round?
Amytrx Therapeutics's most recent funding round was Series A on May 25, 2022.
Who are the main investors in Amytrx Therapeutics?
Investor information for Amytrx Therapeutics is not publicly disclosed.
Will Amytrx Therapeutics IPO soon?
No public IPO plans have been announced for Amytrx Therapeutics.
How can I track Amytrx Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amytrx Therapeutics's secondary market activity and sign up for updates.